Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both ...

After spending nearly two decades in the financial payments sector before transitioning to healthcare, I feel that I’ve gained unique insights into how principles from traditional financial ...

When I was in business school in 2016, I wrote a composition on Blockchain and its implications in healthcare. At the time, all the experts proclaimed confidently that this new technology would ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...